FDA Investigator Brooke K Higgins

Brooke K Higgins has conducted inspections on 223 sites in 10 countries as of 19 May 2015. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:

223

Last Inspection Date:

19 May 2015

Investigator Role:

FDA Investigator

Redica ID:

100000997

Countries of Inspections:

United States of America, Spain, United Kingdom of Great Britain and Northern Ireland, Ireland, Germany, Mexico, Italy, Netherlands, Finland, France

FDA Investigators that have inspected at least one site in common with Brooke K Higgins:

Adriana N Jimenez Lopez, Aimee Cunningham, PhD, Alberto A Viciedo, Alice S Tsao, Alicia M Mozzachio, Alison N Stieg, Allen F Hall, Amber G Chung, Amos C Epps, Amy Devlin, PhD, Amy N Chen, Ana P Pineda Zavaleta, Anastasia G Lolas, Anastasia I Onuorah, Anastasia M Shields, Andrea Siegel, PhD, Andrew O Ejiofor, Angela E Glenn, Anjali Shukla, PhD, Anna Lazar, Annet R Rajan, Anthony F Lorenzo, Anthony W Lee, Arie C Menachem, Arindam Dasgupta, PhD, Asamoah Asamoah, Ashar P Parikh, Atul J Agrawal, Azeezat M Lawal, Azza Talaat, Barbara A Gullick, Barbara J Holladay, Benjamin J Smith, Bijoy Panicker, Billingsley, Bo Chi, PhD, Brandon L Mariner, Brenda W Uratani, PhD, Brian L Belz, Brian M Janelsins, PhD, Brian R Yaun, Brooke K Seeman, Bruce C Kovak, Burnell M Henry, Camerson E Moore, Candice C Mandera, Candice J Cortes, Carla A Norris, Carol L Rehkopf, Carol Rivera Lopez, PhD, Carole L Jones, Caroline Strasinger, Carrie L Doupnik, Caryn M Mcnab, CDR Ileana Barreto Pettit, Cecil D Mitchell, Chaltu Nwakijra, Charlean R Butler, Charles D Boison, Charles R Cote, RIC, Cheryl A Clausen, Cheryl Love Harris, Chiang Syin, PhD, Chris A Sack, Christian D Lynch (CDL), Christina K Theodorou, Christine W Twohy, Christopher L Taste, Christopher R Richardson, Chryste D Best, Claire M Minden, Clarice J Ahn, Clinton J Lott, Cody D Rickman, Colleen F Hoyt, Colleen Thomas, PhD, Collins M Mason, Concepcion Cruz, Jr, Conrad M Guardia, Craig A Garmendia, Cynthia A Harris, MD, RN, Cynthia T Cain, Daniel R Azar, David A Oluwo, David J Gomes, David L Chon, Deborah J Parris, Dell S Moller, Demitria J Xiradakis, Dennis Cantellops Paite, Dennis L Doupnik, Derek S Smith, PhD, Deyaa Shaheen, Dhaval H Patel, Diane L Raccasi, Diane T Bargo, Diane T O'brien, Dianne H Milazzo, Dianne S Alexander, Dirk L Lincoln, Djamila Harouaka, Doan T Nguyen, PharmD, Donald C Obenhuber, PhD, Donald L Lech, Douglas A Campbell, Douglas C Kovacs, Dr. Abhijit Raha, PhD, Dr. Carmelo Rosa, Dr. Dominick Roselle, Dr. Gang Wang, PhD, Dr. Gopa Biswas, PhD, Dr. Ralph M Bernstein, PhD, Dr. Robert C Horan, MD, Dr. Roslyn F Powers, Dr. Sriram Subramaniam, PhD, Dr. Yubing Tang, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Edward P Potter, Edwin Melendez, Eileen A Liu, Elise A Murphy, Elizabeth Ll Edwards, Elvis D Morton, Emest F Bizjak, Emily Leongini, Emmanuel A Dimaano, Jr, Ephrem Hunde, PhD, Eric L Dong, BS, Erin L Mcfiren, Esaw, Fabian Nchaparro Rodriguez, Felix Maldonado, Frances Namuswe, PhD, Frank W Perrella, Frederick F Razzaghi, Gale L Glinecki, Gayle S Lawson, Geneve M Maxwell, Geneve M Parks, George Pyramides, Gerald B Seaborn, Jr, Gerald D Bromley, Jr, Gerald Mierle, Gerardo Z Vazquez, Gifford Whitehurst, Jr, Guerlain Ulysse, Gwyn G Dickinson, Haijing Hu, Haoheng Yan, PhD, Heath A Gerber, Hector Jcolon Torres, Helen B Ricalde, Hongna Wang, Howard Anderson, PhD, Huixia Zhang, Jacqueline A O'shaughnessy, PhD, Jacqueline Johnson, Jacqueline Mdiaz Albertini, Jai P Singh, James C Maclaughlin, James M Mason, James M Simpson, James Norman, James P Mcreavey, James W Leonette, Jamie D Richardson, Janet A Rajan, Jason D Tenney, Jazmine N Still, Jean Blackston Hill, Jee Chung, PhD, Jeffrey A Sommers, Jeffrey D Meng, Jennifer Swisher, PhD, Jesse P Hardin, Jessica Hankins, PhD, Jessica L Pressley, Jessica P Mcalister, Jingbo Xiao, Joanne E King, Joey C West, Jogy George, John A Kadavil, PhD, John D White, John Dan, John M Gusto, John P Mistler, Johnna L Bleem, Johnny D Nwankwo, Johnson, Jonah S Ufferfilge, Jonathan W Chapman, Jorge L Gonzalez, Jorge L Guadalupe, Jose A Lopez, Jose M Cayuela, Jose R Hernandez, Joseph L Despins, PhD, Joseph W Matthews, Joshua P Wireman, Juan Rjimenez Garcia, Junho Pak, Justin A Boyd, Justin A Hefferman, Kalavati Suvarna, PhD, Karen A Briggs, Karen A Spencer, Katelyn Astaub Zamperini, Kathleen M Jordan, Kathy Lee, Kayla V Sprague, Keith M Reilly, Kellia N Hicks, Kelly L Anderson, Kenneth H Williams, Kenneth L Smalls, Kenneth M Gordon, Kenneth Nieves, Ko U Min, Kristina L Conroy, Kshitij A Patkar, Kyle S Hobson, La Tasham Gunter, Lakisha M Williams, Lakshmi Narasimhan, PhD, Larry K Austin, Latorie S Jones, Latoya S Oliver Powell, Laurianne M Montonye, Laurimer Kuilan Torres, Laurissa S Flowers, Lawrence Harmon, Jr, Lawrence J Stringer, LCDR Anastasia M Piliafas Brown, LCDR Debra Emerson, LCDR Matthew R Mcnew, MPH, REHS/RS, LCDR Wilfred A Darang, Li Lu, PhD, Liatte Kreuger, PharmD, Libia M Lugo, Linda F Murphy, Linda J Eason, Linda Linh N Adams, Lisa B Orr, Lisa L Flores, Logan T Williams, Lori A Holmquist, Lori S Lawless, LT Luis O Rodriguez, LT Richard A Lyght, Luella J Rossi, Luis A Dasta, Luis Mburgos Medero, Lynette P Salisbury, Madushini Dharmasena, PhD, Malgorzata G Norton, PhD, Marc S Neubauer, Marcellinus D Dordunoo, Marcia D Fields, Marcus A Ray, Margaret H Waters, Margaret M Annes, Margaret M Doherty, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Marie F Morin, Marion Michaelis, Marion W Nadeau, Marisol Faberlle, Martin K Yau, PhD, Mary E Farbman, PhD, Mary K Leslie, Massoud Motamed, Matthew M Henciak, Meisha R Sampson, Meisha Waters, Melissa J Garcia, Melissa T Roy, Merideth K Rose, Michael A Taylor, Michael F Skelly, PhD, Michael G Truchan, Michael J Vardon, Michael L Casner, Michael Shanks, MS, Michele L Forster, PhD, Michelle Marsh, Mihaly S Ligmond, Mindy M Chou, Mohamad A Chahine, Monique Rac Lester, Mra Digiuliod, Mra Mcculloughj, Muna Algharibeh, Nadeem I Chaudhry, Nancy G Schmidt, Nancy L Meade, Nancy M Espinal, Nathaniel R Esaw, Nawab A Siddiqui, Nebil A Oumer, Nelson N Ayangho, Nerizza B Guerin, Nicholas A Violand, Nicole K Trudel, Nina Yang, Norman K Starks, Normica G Facey, Olaide Akinmade, Omotunde O Osunsanmi, Pal S Mayasandra, Paraluman S Leonin, Parul M Patel, Patricia A Morrow, Patricia D Stahnke, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Paul L Figarole, Jr, Paula J Bretz, Pelekakis, Prabhu P Raju, Pratik S Upadhyay, DDC, Qin Xu, Quyen T Tran, Rabin N Ghoshal, Rachael O Oyewole, Rachel C Harrington, Raymond W Niles, Reba A Gates, Rebecca E Dombrowski, Rebecca Rodriguez, Regina Gibson Melton, Regina T Brown, Renisha M Shaw, Richard H Penta, Richard Ledwidge (nmi), PhD, Richard W Thornton, Rina Bhikha, Robert H Wittorf, Robert J Ham, Robert J Maffei, Robert J Martin, Robert M Barbosa, Robin Levis, PhD, Rodney G Raiford, Ronald T Nowalk, Rosanna M Goodrich, Rose Ashley, Roseline N Boateng, Roy R Rinc, Ruark Lanham, Russell J Glapion, Saleem A Akhtar, Sam H Haidar, PhD, Sam Pepe, Samina S Khan, Samuel H Chan, PharmD, Sanket N Patel, Santos E Camara, Sarah E Mcmullen, Satheesh Thomas, Scott R Nichols, PhD, Scott T Panagiotis, Sean R Marcsisin, Sean R Moynihan, MPH, Sean Y Kassim, PhD, Seema S Singh, Sena G Dissmeyer, Shadia Zaman, PhD, Sharon K Thoma, PharmD, Sherry L Secrist, BLT DO, Shirshendu K Deb, PhD, Shusheen A Alexander, Sierra M Shockley, Simone E Pitts, Sina Shojaee, Sixto M Mercado Rios, Slatten, Sneha S Patel, Srinivas R Chennamaneni, PhD, Stacey A Priest, Stacie A Woods, Stephanie Mangigian, MS/OSH, RN, Stephen C Eason, Stephen D Brown, Steven C Madzo, Steven E Bowen, PhD, Steven J Thurber, Steven Kozlowski, MD, Steven P Donald, Susan J Essenmacher, Susan M Jackson, Susan O Oladeji, Susan P Bruederle, Susan T Hadman, Susanna E Ford, Suzanne M Healy, Suzanne M Muchene, Swati Verma, Sylvia R Dooling, Tajah L Blackburn, Tamal K Chakraborti, PhD, Tamara L Ely, Tamara N Champion, Tamika White, Tamil Arasu, PhD, Tammara A Stephens, Tania E Vizcaino, Teegan Dellibovi Ragheb, PhD, Temar Q Williams, Thai D Truong, Theresa M Smedley, Thomas E Friel, Thomas J Arista, Thomas J Hudson, Thomas R Withers, Thuy T Nguyen, LCDR, Tiffani D Wilson, Tiki J Dixon, Tonia F Bernard, Torrance J Slayton, Toyin B Oladimeji, Truong Xuan Nguyen (Andy), Vesna V Stanoyevitch, Vilmary Negron Rodriguez, Vipulchandra N Dholakia, Viviana Matta, Vivin George, Walden H Lee, Walter L Fava, Wanda Y Fields, Wanda Y Honeyblue, Wayne E Seifert, Wayne L Jefferson, Wendy G Tan, PhD, William A Warnick, William H Linkroum, William J Leonard, William L Bargo, Xiandong Meng, Xiaoshi N Wang, Xikui Chen (nmi), PhD, Xu Michael Di, PhD, Yan Qin, Yasamin Ameri, Yih Chain Huang, PhD, Yiyue Zhang (nmi), PhD, Yumi J Hiramine, Yvins Dezan, Yvonne C Mcknight, Zhao Wang, PhD, Zhenzhen Liu, PhD, Zhong Li, PhD, Zhongren Wu, Zi Qiang Gu

Brooke K Higgins's Documents

Publish Date	Document Type	Title
August, 2013	EIR	Barr Laboratories Inc. - EIR, 2013-08-23
July, 2013	FDA 483	Bell-More Labs Inc - Form 483, 2013-07-25
October, 2004	FDA 483	DanChem Technologies Inc - Form 483, 2004-10-05
March, 2014	FDA 483	Fareva Richmond, Inc. - Form 483, 2014-03-07
May, 2009	FDA 483	Boehringer Ingelheim Chemicals, Inc. - Form 483, 2009-05-13
June, 2004	FDA 483	Atley Pharmaceuticals, Inc. - Form 483, 2004-06-24
June, 2005	FDA 483 Response	Total Homecare Inc. - Form 483R, 2005-06-10
December, 2004	FDA 483	Patient First Corporation - Form 483, 2004-12-09
October, 2007	FDA 483	Afton Scientific, LLC - Form 483, 2007-10-23
June, 2005	FDA 483	Total Homecare Inc. - Form 483, 2005-06-06
March, 2006	FDA 483	Cangene BioPharma, LLC - Form 483, 2006-03-31
March, 2014	FDA 483	Mylan Pharmaceuticals Inc. - Form 483, 2014-03-21
April, 2012	FDA 483	Boehringer Ingelheim Chemicals, Inc. - Form 483, 2012-04-04
February, 2006	FDA 483	Actavis Mid-Atlantic, LLC. - Form 483, 2006-02-17
August, 2005	FDA 483 Response	Exelead, Inc. - Form 483R, 2005-09-15
April, 2010	FDA 483	Barr Laboratories Inc. - Form 483, 2010-04-08
August, 2005	EIR	Exelead, Inc. - EIR, 2005-08-19
March, 2008	FDA 483	Fareva Richmond, Inc. - Form 483, 2008-03-13
August, 2012	FDA 483 Response	Merck Sharp & Dohme LLC - Form 483R, 2012-09-10
June, 2007	EIR	Actavis Mid-Atlantic, LLC. - EIR, 2007-06-22
July, 2010	FDA 483	Merck Sharp & Dohme LLC - Form 483, 2010-07-09
May, 2010	FDA 483	Fareva Richmond, Inc. - Form 483, 2010-05-14
June, 2003	EIR	Mylan Pharmaceuticals Inc. - EIR, 2003-06-17
September, 2011	FDA 483	Afton Scientific, LLC - Form 483, 2011-09-26
May, 2013	FDA 483	Fareva Richmond, Inc. - Form 483, 2013-05-30
May, 2015	FDA 483	NIH Clinical Center Pharmacy Department - Form 483, 2015-05-29
May, 2011	EIR	Pharmaceutics International, Inc. - EIR, 2011-05-25
December, 2012	FDA 483	Orion Corporation - Form 483, 2012-12-20
August, 2013	FDA 483	Barr Laboratories Inc. - Form 483, 2013-08-23
May, 2013	FDA 483	United Therapeutics Corporation - Form 483, 2013-05-29
August, 2012	EIR	Merck Sharp & Dohme LLC - EIR, 2012-08-24
February, 2013	EIR	PETNET SOLUTIONS, INC. - EIR, 2013-02-19
January, 2004	EIR	Reckitt Benckiser Pharmaceuticals Inc - EIR, 2004-01-23
March, 2007	FDA 483	Neilgen Pharmaceutical Inc Dba Unigen Pharmaceuticals - Form 483, 2007-03-22
July, 2003	EIR	Fareva Richmond, Inc. - EIR, 2003-07-18
February, 2013	FDA 483	SOFIE Co. dba SOFIE - Form 483, 2013-02-01
September, 2004	EIR	Boehringer Ingelheim Chemicals, Inc. - EIR, 2004-09-13
February, 2012	FDA 483	PETNET SOLUTIONS, INC. - Form 483, 2012-02-07
April, 2008	FDA 483	Bell-More Labs Inc - Form 483, 2008-04-23
February, 2010	FDA 483	Chempacific Corporation - Form 483, 2010-03-19
June, 2005	EIR	Total Homecare Inc. - EIR, 2005-06-06
February, 2008	FDA 483	Neilgen Pharmaceutical Inc Dba Unigen Pharmaceuticals - Form 483, 2008-02-15
May, 2011	FDA 483	Merck Sharp & Dohme LLC - Form 483, 2011-05-12
July, 2012	EIR	Barr Laboratories Inc. - EIR, 2012-07-26
April, 2013	EIR	Teva Biopharmaceuticals USA - EIR, 2013-04-17
September, 2006	FDA 483	Boehringer Ingelheim Chemicals, Inc. - Form 483, 2006-09-15
February, 2009	FDA 483	Fareva Richmond, Inc. - Form 483, 2009-02-27
February, 2012	EIR	Reckitt Benckiser Pharmaceuticals Inc - EIR, 2012-02-15
October, 2009	FDA 483	Merck Sharp & Dohme LLC - Form 483, 2009-10-01
June, 2008	FDA 483 Response	Actavis Mid Atlantic LLC - Form 483R, 2008-07-30
May, 2011	FDA 483	Pharmaceutics International, Inc. - Form 483, 2011-05-25
June, 2013	FDA 483	Afton Scientific, LLC - Form 483, 2013-06-24
May, 2013	EIR	United Therapeutics Corporation - EIR, 2013-05-29
June, 2004	FDA 483	DanChem Technologies Inc - Form 483, 2004-06-23
August, 2011	FDA 483	Barr Laboratories Inc. - Form 483, 2011-08-25
September, 2006	FDA 483	Merck Sharp & Dohme LLC - Form 483, 2006-09-29
February, 2005	FDA 483	East Coast Oxygen & Hydro Testing Inc. - Form 483, 2005-02-18
August, 2010	FDA 483	Cangene BioPharma, LLC - Form 483, 2010-08-27
June, 2008	FDA 483	Actavis Mid Atlantic LLC - Form 483, 2008-06-27
August, 2005	FDA 483	Exelead, Inc. - Form 483, 2005-08-19
April, 2014	FDA 483	Afton Scientific, LLC - Form 483, 2014-04-25
December, 2006	EIR	F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. - EIR, 2006-12-13
February, 2013	EIR	IBA Molecular North America Inc. - EIR, 2013-02-01
October, 2009	FDA 483	Jubilant Cadista Pharmaceuticals, Inc. - Form 483, 2009-10-29
March, 2004	FDA 483	Virginia Commonwealth University - Form 483, 2004-03-03
September, 2004	FDA 483	Boehringer Ingelheim Chemicals, Inc. - Form 483, 2004-09-13
October, 2004	FDA 483	Fareva Richmond, Inc. - Form 483, 2004-10-08
September, 2013	EIR	Merck Sharp & Dohme LLC - EIR, 2013-09-30
January, 2011	FDA 483	Bell-More Labs Inc - Form 483, 2011-01-26
September, 2002	EIR	Union Carbide Corporation, Subsidiary of Dow Chemical Compan - EIR, 2002-09-24
October, 2012	FDA 483	AG Essence Inc - Form 483, 2012-10-16
March, 2011	FDA 483	Carilion Materials Management - Form 483, 2011-03-02
February, 2014	FDA 483	RX South DBA RX3 Compounding Pharmacy LLC - Form 483, 2014-02-21
April, 2014	EIR	Cangene BioPharma, LLC - EIR, 2014-04-09
April, 2014	FDA 483	Cangene BioPharma, LLC - Form 483, 2014-04-09
April, 2012	EIR	Boehringer Ingelheim Chemicals, Inc. - EIR, 2012-04-04
March, 2005	FDA 483	Fareva Richmond, Inc. - Form 483, 2005-03-31
September, 2013	FDA 483	Merck Sharp & Dohme LLC - Form 483, 2013-09-30
August, 2012	FDA 483	Merck Sharp & Dohme LLC - Form 483, 2012-08-24
June, 2012	FDA 483	Pharmaceutics International, Inc. - Form 483, 2012-06-01
July, 2011	FDA 483	Cangene BioPharma, LLC - Form 483, 2011-07-22
March, 2014	EIR	Mylan Pharmaceuticals Inc. - EIR, 2014-03-21
December, 2012	EIR	Orion Corporation - EIR, 2012-12-20
December, 2010	FDA 483	Pharmaceutics International, Inc. - Form 483, 2010-12-16
June, 2013	EIR	Afton Scientific, LLC - EIR, 2013-06-24
March, 2013	FDA 483	Olympia Compounding Pharmacy - Form 483, 2013-03-21
August, 2006	FDA 483	Bell-More Labs Inc - Form 483, 2006-08-17
October, 2004	FDA 483	Biovail Technologies Ltd. - Form 483, 2004-10-29

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more